ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
424B4 Nov 14, 2025 PROSPECTUS SUPPLEMENT
424B4 Nov 14, 2025 PROSPECTUS SUPPLEMENT
8-K Nov 3, 2025 CURRENT REPORT
10-Q Nov 3, 2025 QUARTERLY REPORT
8-K Oct 30, 2025 CURRENT REPORT
8-K/A Sep 12, 2025 AMENDMENT NO. 1 TO FORM 8-K
424B4 Aug 15, 2025 PROSPECTUS SUPPLEMENT
424B4 Aug 15, 2025 PROSPECTUS SUPPLEMENT
424B4 Aug 15, 2025 PROSPECTUS SUPPLEMENT
424B4 Aug 15, 2025 PROSPECTUS SUPPLEMENT
424B4 Aug 15, 2025 PROSPECTUS SUPPLEMENT
8-K Aug 14, 2025 CURRENT REPORT
SCHEDULE 13G/A Aug 13, 2025
10-Q Aug 13, 2025 QUARTERLY REPORT
8-K/A Jul 18, 2025 AMENDMENT NO. 1 TO FORM 8-K
SCHEDULE 13D/A Jul 15, 2025
S-8 Jun 27, 2025 REGISTRATION STATEMENT
8-K Jun 4, 2025 CURRENT REPORT
SCHEDULE 13D Jun 3, 2025
8-K/A May 30, 2025 FORM 8-K/A
POS AM May 27, 2025 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
POS AM May 27, 2025 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1
POS AM May 27, 2025 POST-EFFECTIVE AMENDMENT NO. 6 TO FORM S-1
S-3 May 22, 2025 REGISTRATION STATEMENT
EFFECT May 20, 2025
← Newer Page 2 of 32 · 793 filings Older →